Vixiar (Series A)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$8,475,910
Company Info
Founders
Kevin Thibodeau
Market
Healthcare & Wellness
Company Description

Manufacturer of non-invasive devices intended to monitor cardiopulmonary diseases. Vixiar Medical develops non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases.